Stockscreener 앱 받기
1.515
12.22%
0.165
시간 외 거래:
1.50
-0.015
-0.99%
Neuronetics Inc 주식(STIM)의 최신 뉴스
STIM (NASDAQ: STIM) Form 144: insider resale notice for 16,005 shares - Stock Titan
STIM (NASDAQ: STIM) notice: proposed sale of 46,289 common shares - Stock Titan
Canaccord Genuity Group Lowers Neuronetics (NASDAQ:STIM) Price Target to $3.00 - MarketBeat
STIM: Neuronetics Analyst Rating UpdateMarch 19, 2026 | STIM Stock News - GuruFocus
Neuronetics, Inc. (NASDAQ:STIM) Q4 2025 Earnings Call Transcript - Insider Monkey
[Form 4] Neuronetics, Inc. Insider Trading Activity - Stock Titan
Neuronetics (STIM) EVP receives 33,750 performance-based common shares - Stock Titan
Neuronetics (STIM) CFO awarded 25,000 RSUs vesting from 2027 - Stock Titan
This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain - AOL.com
Neuronetics to Spotlight Expanding Mental Health Therapies at Major Industry Forum - MSN
Canaccord cuts Neuronetics stock price target on valuation shift By Investing.com - Investing.com India
Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 531,000 Shares - MarketBeat
Insider Buying: Jorey Chernett Acquires 531,000 Shares of Neuron - GuruFocus
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names - AOL.com
Neuronetics Insider Bought Shares Worth $615,960, According to a Recent SEC Filing - marketscreener.com
Neuronetics 10% Owner Purchased Shares Worth Over $615K - TradingView
Large Neuronetics (STIM) insider purchase adds 531,000 shares at $1.16 - Stock Titan
Large Neuronetics (STIM) holder discloses 6,985,404-share position - Stock Titan
Prenuvo CEO bets he can save lives and major healthcare spending by ‘inverting the pyramid’ - AOL.com
Canaccord cuts Neuronetics stock price target on valuation shift - Investing.com
Neuronetics, Inc. Stock Plummets to New 52-Week Low of $0.80 - Markets Mojo
[SCHEDULE 13G/A] Neuronetics, Inc. Amended Passive Investment Disclosure - Stock Titan
Neuronetics revenue up 86% to USD 41.8M in Q4 2025 - Medical Buyer
Neuronetics names Dan Reuvers as CEO effective March 23 By Investing.com - Investing.com India
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), some existing shareholders of Neuronetics Inc. plan to sell up to 20.7 million shares of the company's common stock. - Bitget
Neuronetics (NASDAQ: STIM) registers resale of 20.7M shares by Madryn holders - Stock Titan
Neuronetics appoints Dan Reuvers as President and CEO - TipRanks
Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch - MSN
Published on: 2026-03-18 12:34:36 - baoquankhu1.vn
STIM Volatility: Market Contemplates Latest Economic Pressures and Investor Positioning - StocksToTrade
Malvern-based Neuronetics appoints new CEO, revenue surges after acquisition - The Business Journals
Parian Ultreia reports 7.0% stake in Neuronetics (NASDAQ: STIM) — 4.84M shares - Stock Titan
Neuronetics CEO Transition & Financial Reporting Practices | Leadership UpdateNews and Statistics - IndexBox
Neuronetics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Neuronetics Surges As Stock Price Experiences Notable Shift - timothysykes.com
Neuronetics Reports Record 2025 Financial Results, Greenbrook Clinic Growth, and 2026 Outlook with New CEO Appointment - Minichart
Neuronetics (STIM) Q4 2025 Earnings Transcript - The Globe and Mail
Neuronetics (STIM) Announces New CEO, Shares Surge - GuruFocus
Neuronetics Q4 Earnings Call Highlights - Yahoo Finance
Neuronetics earnings missed by $0.01, revenue topped estimates - Investing.com Canada
Earnings call transcript: Neuronetics Q4 2025 sees revenue growth, EPS miss - Investing.com
Neuronetics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Neuronetics 2025 Financial Results: Q4 Revenue $41.8M, Annual Loss $39MNews and Statistics - IndexBox
Neuronetics Appoints New CEO to Lead Next Growth Phase - TipRanks
NEURONETICS ($STIM) Releases Q4 2025 Earnings - Quiver Quantitative
Neuronetics names Dan Reuvers as CEO effective March 23 - Investing.com
Neuronetics (NASDAQ:STIM) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Neuronetics : STIM Corporate Presentation March 2026 - marketscreener.com
Neuronetics: Q4 Earnings Snapshot - Barchart
Neuronetics appoints Dan Reuvers as president and chief executive officer - marketscreener.com
Neuronetics 2025 10-K: Revenue $149.2M, Net Loss $39.1M - TradingView
Neuronetics Q4 revenue rises, appointes Dan Reuvers as CEO - TradingView
Neuronetics (NASDAQ: STIM) nearly doubles 2025 revenue but stays unprofitable - Stock Titan
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - The Manila Times
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer - The Manila Times
Neuronetics (NASDAQ: STIM) doubles 2025 revenue, narrows loss and hires new CEO - Stock Titan
Neuronetics, Inc. Appoints Dan Reuvers as President and CEO - Quiver Quantitative
BRIEF-Neuronetics Q4 Gross Margin 52% - TradingView
Mental-health device firm Neuronetics brings in growth-focused CEO - Stock Titan
Neuronetics (STIM) Reports Strong Revenue Growth in Q4 - GuruFocus
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Up 22.2% in February - MarketBeat
Neuronetics (STIM) stock rises 41% after hours: What's going on? - MSN
Neuronetics, Inc. Hits New 52-Week Low at $1.19 Amid Declining Stock Performance - Markets Mojo
STIM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Neuronetics to Report Fourth Quarter 2025 Results March 17 - MyChesCo
Neuronetics Gains Breakthrough as New York Medicaid Expands Coverage for TMS Depression Therapy - MSN
Neuronetics, Inc. (STIM) Positions as Neurohealth Leader with Adolescent Breakthrough - MSN
Malvern-based Neuronetics reports preliminary 2025 revenue growth and positive cash flow - MSN
Can Neuronetics Inc. stock sustain free cash flow growth2025 Geopolitical Influence & Verified Technical Trade Signals - Naître et grandir
Aug Momentum: Can Neuronetics Inc outperform in the next rallyBuy Signal & Weekly High Potential Stock Alerts - baoquankhu1.vn
Volatility Watch: Why is Neuronetics Inc stock going upMarket Trend Review & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
0.85%
1.86%
자본화:
|
볼륨(24시간):